BOSTON & NEW YORK--(BUSINESS WIRE)--AVAVA, Inc., an innovative medical aesthetics platform company advancing a new class of image-guided, focused intradermal laser products that are safe and effective for all skin tones, today announced that it secured $35 million in new financing.

波士顿和纽约--（商业新闻短讯）--创新医学美学平台公司AVAVA，Inc.今天宣布，它获得了3500万美元的新融资，该公司推出了一类新的图像引导，聚焦皮内激光产品，对所有肤色都安全有效。

AVAVA successfully completed its Series C round, which raised $25 million in proceeds from new and existing investors including its strategic partner, Jeisys Medical, Inc.

AVAVA成功完成了C轮融资，从包括其战略合作伙伴Jeisys Medical，Inc.在内的新投资者和现有投资者那里筹集了2500万美元的资金。

The company also secured $10 million in growth capital from Catalio Capital Management, LP, a leading multi-strategy investment firm focused on the healthcare and life sciences industries. The investment comes from the Catalio Structured Opportunities Fund, which provides structured financing solutions to innovative healthcare and life sciences companies..

该公司还从专注于医疗保健和生命科学行业的领先多策略投资公司Catalio capital Management，LP获得了1000万美元的增长资本。该投资来自Catalio结构化机会基金，该基金为创新的医疗保健和生命科学公司提供结构化融资解决方案。。

The financing enables the company to move forward in its deep pipeline of products and ambitious global expansion plans already approved by AVAVA’s board of directors. Most notably, the funding will further accelerate the commercialization of its flagship product, MIRIA, the first of a new class of aesthetic dermatology lasers utilizing proprietary Focal Point Technology™ to deliver energy with pinpoint accuracy anywhere in the skin, greatly enhancing skin revitalization outcomes for patients of all skin tones..

这笔融资使该公司能够推进其深层次的产品线和已获得AVAVA董事会批准的雄心勃勃的全球扩张计划。最值得注意的是，这笔资金将进一步加速其旗舰产品MIRIA的商业化，MIRIA是利用专有Focal Point Technology™的新型美容皮肤病激光器中的第一个，它可以在皮肤的任何地方精确传递能量，大大提高所有肤色患者的皮肤再生效果。。

“This financing represents an important moment in AVAVA's journey as we move forward in our mission to revolutionize the aesthetics industry,' said Dr. Irina Erenburg, CEO of AVAVA. “We are excited to continue our expansion plans and advance the next generation of products in our pipeline, while delivering best-in-class treatments for individuals in need.

AVAVA首席执行官伊琳娜·埃伦伯格（IrinaErenburg）博士表示：“随着我们朝着彻底改变美学行业的目标迈进，这笔融资代表了AVAVA旅程中的一个重要时刻。我们很高兴继续我们的扩张计划，推进下一代产品的开发，同时为有需要的个人提供一流的治疗。

We are grateful to be collaborating with Catalio, Jeisys, and our other investor partners in this journey, who all bring invaluable guidance, industry expertise, track records of success, and a shared vision.”.

我们非常感谢在这段旅程中与Catalio、Jeisys和我们的其他投资者合作伙伴合作，他们都带来了宝贵的指导、行业专业知识、成功记录和共同的愿景。”。

AVAVA’s platform, the latest innovation from pioneering scientific founders Dr. R. Rox Anderson, Dr. Dieter Manstein, and Dr. Henry Chan, offers safe and effective solutions for individuals with diverse skin tones, providing precision energy delivery while minimizing collateral damage. The company’s commitment to innovation, coupled with its dedication to meeting the evolving needs of customers, has positioned it as an emerging leader in medical aesthetics..

AVAVA的平台是先驱科学创始人R.Rox Anderson博士、Dieter Manstein博士和Henry Chan博士的最新创新，为不同肤色的个体提供安全有效的解决方案，提供精确的能量输送，同时最大程度地减少附带损害。该公司致力于创新，并致力于满足客户不断变化的需求，使其成为医学美学领域的新兴领导者。。

“As a leading investor in cutting-edge healthcare technologies, Catalio is thrilled to partner with AVAVA as the company continues to make remarkable progress,” said Jonathan Blankfein, Partner & Portfolio Manager at Catalio Capital Management. “This investment further demonstrates our firm’s commitment to working with disruptive and innovative companies not just as an investor, but as a long-term strategic partner.

Catalio Capital Management合伙人兼投资组合经理乔纳森·布兰克费恩（JonathanBlankfein）表示：“作为尖端医疗保健技术的领先投资者，Catalio很高兴与AVAVA合作，因为该公司继续取得显著进展。”。“这项投资进一步表明，我们公司不仅作为投资者，而且作为长期战略合作伙伴，致力于与颠覆性和创新性公司合作。

We are highly optimistic for what the future holds for AVAVA and for this fast-growing segment of the aesthetics industry.”.

我们对AVAVA的未来以及美学行业这一快速增长的细分市场持高度乐观态度。”。

About AVAVA

关于AVAVA

Born out of Blossom Innovations, AVAVA is offering a new class of intradermal lasers that enable unprecedented customization. By creating a map to personalized skin care through proprietary and patented Focal Point Technology™, and guided by advanced skin imaging, laser energy is delivered at the precise therapeutic depth for optimal results for all skin tones and types..

诞生于Blossom创新，AVAVA提供了一类新的皮内激光，实现了前所未有的定制。通过专有和专利的Focal Point Technology™创建个性化皮肤护理地图，并在高级皮肤成像的指导下，激光能量以精确的治疗深度传递，为所有肤色和类型提供最佳效果。。

About Blossom Innovations

关于Blossom创新

Since our inception, Blossom Innovations has been rooted in deep expertise, unmatched success, and continual collaboration. Founded by some of the most celebrated names in dermatology, today we’re at the forefront of clinical innovation — with seasoned executive leadership, a growing team of dedicated R&D experts, and a dynamic network of industry and research collaborations..

自成立以来，Blossom创新植根于深厚的专业知识、无与伦比的成功和持续的合作。由皮肤病学中一些最著名的名字创立，今天我们处于临床创新的前沿-拥有经验丰富的高管领导，不断壮大的专业研发专家团队，以及充满活力的行业和研究合作网络。。

About Catalio Capital Management

关于Catalio Capital Management

Catalio Capital Management, LP, is a multi-strategy healthcare and life sciences investment firm focusing on breakthrough companies developing the next generation of drugs, devices, diagnostics, and data-driven insights. Catalio's exclusive network includes over 44 world-renowned scientists with extensive academic and scientific achievements who have each started well-established companies based on their research.

Catalio Capital Management，LP是一家多策略医疗保健和生命科学投资公司，专注于开发下一代药物，设备，诊断和数据驱动见解的突破性公司。Catalio的独家网络包括44多名拥有广泛学术和科学成就的世界知名科学家，他们都在自己的研究基础上创办了知名公司。

Catalio has offices in New York and London. Learn more about Catalio Capital Management by visiting www.cataliocapital.com..

加泰利奥在纽约和伦敦设有办事处。访问www.cataliocapital.com，了解更多有关Catalio Capital Management的信息。。

ABOUT Jeisys Medical Inc.

关于Jeisys Medical Inc。

Jeisys Medical Inc., a worldwide medical device manufacturer, produces high-end products for plastic surgeons, dermatologists, physicians, and healthcare professionals. With various reliable product lines including IPL, RF microneedle, CO2, Q-Switch laser and HIFU, Jeisys serves the industry as one of the leading companies with rigorous R&D and valuable experience..

Jeisys Medical Inc.是一家全球医疗器械制造商，为整形外科医生、皮肤科医生、医生和医疗保健专业人员生产高端产品。Jeisys拥有各种可靠的产品线，包括IPL、RF微针、CO2、Q开关激光器和HIFU，是业界领先的公司之一，拥有严格的研发和宝贵的经验。。